Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat

Neuroscience Research

Volumn 66, Issue 1, 2010, Pages 2-6

  Narita, Masaaki ^a,b   Oyabu, Akiko ^b   Imura, Yoshio ^b   Kamada, Naoki ^b   Yokoyama, Tomomi ^b   Tano, Kaori ^b   Uchida, Atsuko ^b   Narita, Naoko ^a,c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b MIE UNIVERSITY   (Japan)

^c BUNKYO UNIVERSITY   (Japan)

Author keywords

Autism model animals; Nonexploratory movement

Indexed keywords

THALIDOMIDE; VALPROIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AUTISM; BEHAVIOR DISORDER; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; LEARNING TEST; LOCOMOTION; MALE; MAZE TEST; MOTOR DYSFUNCTION; NERVE CELL DIFFERENTIATION; NONHUMAN; OPEN FIELD TEST; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SOCIAL INTERACTION; TASK PERFORMANCE;

AGE FACTORS; ANIMALS; AUTISTIC DISORDER; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; INTERPERSONAL RELATIONS; MALE; MAZE LEARNING; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; THALIDOMIDE; VALPROIC ACID;

EID: 73249133910     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.09.001     Document Type: Article

References (23)

1. Anderson G.M., Freedman D.X., Cohen D.J., Volkmar F.R., Hoder E.L., McPhedran P., Minderaa R.B., Hansen C.R., and Young J.G. Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry 28 (1987) 885-900
2. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., Persico A.M., and Levitt P. A genetic variant that disrupts MET transcription is associated with autism. Proceedings of the National Academy of Sciences of the United States of America 103 45 (2006) 16834-16839
3. Charman T., and Baird G. Practitioner review: diagnosis of autism spectrum disorder in 2- and 3-year-old children. Journal of Child Psychology and Psychiatry 43 (2002) 289-305
4. Chugani D.C., Muzik O., Rothermel R., Behen M., Chakraborty P., Mangner T., da Silva E.A., and Chugani H.T. Altered serotonin synthesis in the dentatethalamocortical pathway in autistic boys. Annals of Neurology 42 (1997) 666-669
5. Filipek P.A., Accard P.J., Baranek G.T., Cook Jr. E.H., Dawson G., Gordon B., Gravel J.S., Johnson C.P., Kallen R.J., Lewin G., Levy S.E., Minshew N.J., Ozonoff S., Prizant B.M., Rapin I., Rogers S.J., Stone W.L., Teplin S., Tuchman R.F., and Volkmar F.R. The screening and diagnosis of autistic spectrum disorders. Journal of Autism & Developmental Disorders 29 (1999) 439-484
6. Folstein S.E., and Piven J. Etiology of autism; genetic influences. Pediatrics 87 5 (1991) 767
7. Geier D.A., Kern J.K., Garver C.R., Adams J.B., Audhya T., Nataf R., and Geier M.R. Biomarkers of environmental toxicity and susceptibility in autism. Journal of Neurological Sciences 280 (2009) 101-108
8. Honda H., Shimizu Y., Imai M., and Nitto Y. Cumulative incidence of childhood autism: a total population study of better accuracy and precision. Developmental Medicine & Child Neurology 47 (2005) 10-18
9. Ingram J.L., Peckham S.M., Tisdale B., and Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicology and Teratology 22 (2000) 319-324
10. Lathe R. Autism, Brain and Environment (2006), Jessica Kingsley Publishers
11. Matsubara Y., and Mikami T. Teratogenic potentially of single dose of thalidomide in JW-NIBS rabbits. Jikken Dobutsu Experimental Animals 34 (1985) 295-302
12. McNamara I.M., Bellola A.W., Bialowas L.A., and Whitaker-Azmitia P.M. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Research 1189 (2008) 203-214
13. Miller M.T., and Stromland K. Thalidomide embryopathy: an insight into autism?. Teratology 47 (1993) 387-388
14. Miyazaki K., Narita N., and Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. International Journal of Developmental Neuroscience 23 (2005) 287-297
15. Muhle R., Trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 113 5 (2004) e472-e486
16. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., and Okado N. Increased monoamine concentration in the brain and the blood of fetal thalidomide and valproic acid exposed rat; putative animal models for autism. Pediatric Research 52 (2002) 576-579
17. Olton D.S., and Samuelson R.J. Remembrance of places past: spatial memory in rats. Journal of Experimental Psychology; Animal Behavior. Processes 2 (1976) 97-116
18. Pierce K., and Courchesne E. Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biological Psychiatry 49 8 (2001) 655-654
19. Rice D., and Borone. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environmental Health Perspectives 108 (2000) 511-533
20. Sadamatsu M., Kanai H., Xu X., Liu Y., and Kato N. Review of animal models of autism: implications of thyroid hormone. Congenital Anomalies 46 (2006) 1-9
21. Schneider T., and Przewtcki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30 (2005) 80-89
22. Stromland K., Nordin V., Miller M., Akerstrom B., and Gillberg C. Autism in thalidomide embryopathy: a population study. Developmental Medicine and Child Neurology 36 (1994) 351-356
23. Williams G., King J., Cunningham M., Stephan M., Kerr B., and Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Developmental Medicine and Child Neurology 43 (2001) 202-206